Punit Dhillon is listed as an executive officer and director on 16 SEC Form D filings by 4 issuers between Jul 2011 and Mar 2024: Skye Bioscience, Inc. (San Diego, CA — biotechnology — 2018–2024; $62.3M reported sold to 43 investors), ONCOSEC MEDICAL Inc (Ewing, NJ — biotechnology — 2011–2017; $5.69M reported sold to 9 investors), Emerald Health Pharmaceuticals Inc. (San Diego, CA — pharmaceuticals — 2017–2021; $2.5M reported sold to 5 investors) and Emerald Health Bioceuticals Inc. (San Diego, CA — retailing — 2017–2020; $127K reported sold to 8 investors).
What this means A repeat sponsor — 4 separate companies raised money with this person listed as executive officer and director, over about 13 years. Across those companies the filings report $70.6M sold in total.
Listed alongside Avtar Dhillon (6 shared filings), James DeMesa (6 shared filings), Gaetano Morello (5 shared filings), Jim Heppell (5 shared filings), James L. Heppell (4 shared filings) and 30 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Punit. Each name links to their own page.
2 of the issuers belong to the sponsor group Emerald Health (3 issuers, $712K reported sold, 2017–2022).
What this means A sponsor group is one team that sets up a new company for each deal. Emerald Health has 3 companies on file and $712K reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 16 public filings for Punit Dhillon and found 11 differences: Form D filed 16 days after the first sale; Punit Dhillon's role changed at Skye Bioscience, Inc.: director → executive officer, director; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.